Skip to main content

Table 4 Changes in Cystatin C and MD2 (ng/ml, mean ± SD) between the control group and the RIPC group

From: Effect of remote ischemic preconditioning on perioperative neurocognitive disorder in elderly patients undergoing major surgery and associated genetic variant analysis: a randomized clinical trial

  

Control Group (n = 47)

RIPC Group (n = 43)

P value

Cystatin C

T0

677.91 ± 699.15

519.19 ± 453.1

0.209

 

T1

985.39 ± 587.39*

970.94 ± 390.9****

0.892

 

T3

874.32 ± 583.06

764.2 ± 406.27*

0.306

MD2

T0

7.31 ± 7.02

6.72 ± 6.79

0.690

 

T1

11.75 ± 7.53**

11.58 ± 6.79**

0.908

 

T3

9.82 ± 6.22

9.41 ± 6.36

0.755

  1. *P < 0.05
  2. **P < 0.01
  3. ****P < 0.0001, compared with the preoperative group (T0)
Back to article page

Perioperative Medicine

ISSN: 2047-0525